Iopamidol
Structural formula | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() |
||||||||||||||||||||||
General | ||||||||||||||||||||||
Non-proprietary name | Iopamidol | |||||||||||||||||||||
other names |
1- N , 3- N -bis (1,3-dihydroxypropan-2-yl) -5 - [(2 S ) -2-hydroxypropanamido] -2,4,6-triiodobenzene-1,3-dicarboxamide |
|||||||||||||||||||||
Molecular formula | C 17 H 22 I 3 N 3 O 8 | |||||||||||||||||||||
Brief description |
white to almost white powder |
|||||||||||||||||||||
External identifiers / databases | ||||||||||||||||||||||
|
||||||||||||||||||||||
Drug information | ||||||||||||||||||||||
ATC code | ||||||||||||||||||||||
Drug class | ||||||||||||||||||||||
properties | ||||||||||||||||||||||
Molar mass | 777.08 g · mol -1 | |||||||||||||||||||||
solubility |
Easily soluble in water, very slightly soluble in methanol , practically insoluble in dichloromethane and ethanol |
|||||||||||||||||||||
safety instructions | ||||||||||||||||||||||
|
||||||||||||||||||||||
Toxicological data | ||||||||||||||||||||||
As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions . |
Iopamidol is an active ingredient that contains iodine and is used in medicine as a contrast medium . Administered intravenously, it is used to display blood vessels ( angiography ) during X-ray examinations . It was launched in 1977. Since the active substance is completely excreted via the kidneys , it is also suitable for excretory urography and for determining renal clearance . When administered intrathecally , iopamidol is also used for myelography and visualization of the cerebral ventricles .
The substance is found in surface waters, because sewage treatment plants cannot remove the substance well from the wastewater even with a fourth purification stage, with ozone or activated carbon. See also contrast media .
Trade names
Cetegnost, Iopamigita, Iopamiro, Iopamiron, Isovue, Niopam, Scanlux, Solutrast, Unilux
Individual evidence
- ↑ a b Data sheet IOPAMIDOL CRS (PDF) at EDQM , accessed on September 21, 2009.
- ↑ a b lgcstandards: MSDS ( Memento from August 12, 2014 in the Internet Archive ) (PDF; 173 kB).
- ↑ GWA Milne: Gardner's Commercially Important Chemicals: Synonyms, Trade Names, and ... John Wiley & Sons, 2005, ISBN 0-471-73661-9 , pp. 339 ( limited preview in Google Book search).
- ↑ Andreas Beck: Angiography of the hand diagnostics and therapy . Springer-Verlag, 2013, ISBN 978-3-642-78923-6 , pp. 44 ( limited preview in Google Book search).
- ^ Negotiation report of the German Society for Urology, 36th conference, October 3 to 6, 1984, Bremen . Springer-Verlag, 2013, ISBN 978-3-642-82538-5 , p. 540 ( limited preview in Google Book search).
- ↑ Peter Dawson, Wolfram Clauß: Contrast media in practice . Springer-Verlag, 2013, ISBN 978-3-642-93540-4 , pp. 30 ( limited preview in Google Book search).
- ^ H. Gänshirt, Peter Berlit, G. Haack: Cardiovascular diseases and nervous system neurotoxicology problems of brain death 58th conference. Annual conference from 19.-22. September 1984 in Heidelberg . Springer-Verlag, 2013, ISBN 978-3-642-46521-5 , pp. 511 ( limited preview in Google Book search).
- ↑ Abegglen C., Siegrist H: Micropollutants from municipal wastewater. Process for further elimination in sewage treatment plants. (PDF; 3.5 MB) In: Environmental Knowledge. Federal Office for the Environment, Bern, 2012 .